RCMI Coordinating Center (RCMI CC) Header Logo

Search Results (343)

MatchTypeWhy
Taylor, JamesPerson Why?
The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease.Academic Article Why?
Nekhai, SergeiPerson Why?
Adamkiewicz, ThomasPerson Why?
Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.Academic Article Why?
Invasive infections and sickle-cell disease.Academic Article Why?
"Maximum tolerated dose" vs "fixed low-dose" hydroxyurea for treatment of adults with sickle cell anemia.Academic Article Why?
A case study: Acceptance and commitment therapy for pediatric sickle cell disease.Academic Article Why?
A network model to predict the risk of death in sickle cell disease.Academic Article Why?
A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.Academic Article Why?
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.Academic Article Why?
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.Academic Article Why?
Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia.Academic Article Why?
Ancestry of African Americans with sickle cell disease.Academic Article Why?
Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.Academic Article Why?
Per Page    Page  of 23last Nextnext
Prev
Search Criteria
  • sickle cell disease
Filter by Type
_
Click "Why?" to see why an item matched the search.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support